These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8669679)

  • 21. The action of perchlorate on malignant-hyperthermia-susceptible muscle.
    Anderson LC; Fruen BR; Jordan RC; Louis CF; Gallant EM
    Pflugers Arch; 1997 Dec; 435(1):91-8. PubMed ID: 9359907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The point mutation Arg615-->Cys in the Ca2+ release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia.
    Otsu K; Nishida K; Kimura Y; Kuzuya T; Hori M; Kamada T; Tada M
    J Biol Chem; 1994 Apr; 269(13):9413-5. PubMed ID: 7511586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of contracture tests with halothane, caffeine, and ryanodine depend on different malignant hyperthermia-associated ryanodine receptor gene mutations.
    Fiege M; Wappler F; Weisshorn R; Ulrich Gerbershagen M; Steinfath M; Schulte Am Esch J
    Anesthesiology; 2002 Aug; 97(2):345-50. PubMed ID: 12151923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].
    Fiege M; Wappler F; Scholz J; von Richthofen V; Brinken B; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Sep; 33(9):557-63. PubMed ID: 9787864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of ryanodine receptor agonist 4-chloro-m-cresol on myoplasmic free Ca2+ concentration and force of contraction in mouse skeletal muscle.
    Westerblad H; Andrade FH; Islam MS
    Cell Calcium; 1998 Aug; 24(2):105-15. PubMed ID: 9803311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-Chloro-m-cresol test--a possible supplementary test for diagnosis of malignant hyperthermia susceptibility.
    Ording H; Glahn K; Gardi T; Fagerlund T; Bendixen D
    Acta Anaesthesiol Scand; 1997 Sep; 41(8):967-72. PubMed ID: 9311392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel (ryanodine receptor isoform 1).
    Du GG; Oyamada H; Khanna VK; MacLennan DH
    Biochem J; 2001 Nov; 360(Pt 1):97-105. PubMed ID: 11695996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormality in calcium release from skeletal sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia.
    Nelson TE
    J Clin Invest; 1983 Sep; 72(3):862-70. PubMed ID: 6886007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypes associated with malignant hyperthermia susceptibility in swine genotyped as homozygous or heterozygous for the ryanodine receptor mutation.
    Fletcher JE; Calvo PA; Rosenberg H
    Br J Anaesth; 1993 Sep; 71(3):410-7. PubMed ID: 8398525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease.
    Tong J; Oyamada H; Demaurex N; Grinstein S; McCarthy TV; MacLennan DH
    J Biol Chem; 1997 Oct; 272(42):26332-9. PubMed ID: 9334205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in ryanodine-induced contractures by stimulus frequency in malignant hyperthermia susceptible and malignant hyperthermia nonsusceptible dog skeletal muscle.
    Sudo RT; Nelson TE
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1331-6. PubMed ID: 9316843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study.
    Klingler W; Heiderich S; Girard T; Gravino E; Heffron JJ; Johannsen S; Jurkat-Rott K; Rüffert H; Schuster F; Snoeck M; Sorrentino V; Tegazzin V; Lehmann-Horn F
    Orphanet J Rare Dis; 2014 Jan; 9():8. PubMed ID: 24433488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caffeine stimulation of malignant hyperthermia-susceptible sarcoplasmic reticulum Ca2+ release channel.
    Shomer NH; Mickelson JR; Louis CF
    Am J Physiol; 1994 Nov; 267(5 Pt 1):C1253-61. PubMed ID: 7977689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mg2+ dependence of halothane-induced Ca2+ release from the sarcoplasmic reticulum in skeletal muscle from humans susceptible to malignant hyperthermia.
    Duke AM; Hopkins PM; Halsal JP; Steele DS
    Anesthesiology; 2004 Dec; 101(6):1339-46. PubMed ID: 15564941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suxamethonium chloride and malignant hyperpyrexia.
    Galloway GJ; Denborough MA
    Br J Anaesth; 1986 Apr; 58(4):447-50. PubMed ID: 3954924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro contracture test and gene typing in diagnosing malignant hyperthermia. Each as an appropriate complement to the other method].
    Rüffert H; Olthoff D; Deutrich C; Thamm B; Froster U
    Anaesthesist; 2000 Feb; 49(2):113-20. PubMed ID: 10756965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the serotonin2 receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia-susceptible patients.
    Wappler F; Roewer N; Köchling A; Scholz J; Löscher W; Steinfath M
    Anesthesiology; 1996 Jun; 84(6):1280-7. PubMed ID: 8669667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced inhibitory effect of Mg2+ on ryanodine receptor-Ca2+ release channels in malignant hyperthermia.
    Laver DR; Owen VJ; Junankar PR; Taske NL; Dulhunty AF; Lamb GD
    Biophys J; 1997 Oct; 73(4):1913-24. PubMed ID: 9336187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle].
    Monnier N; Lunardi J
    Ann Biol Clin (Paris); 2000; 58(2):147-56. PubMed ID: 10760701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Similar susceptibility to halothane, caffeine and ryanodine in vitro reflects pharmacogenetic variability of malignant hyperthermia.
    Ginz HF; Girard T; Censier K; Urwyler A
    Eur J Anaesthesiol; 2004 Feb; 21(2):151-7. PubMed ID: 14977348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.